Polyhydramnios or Excessive Fetal Growth Are Markers for Abnormal Perinatal Outcome in Euglycemic Pregnancies
13 March 2017
15 July 2017
24 August 2017 (eFirst)
Objective This study aims to investigate the perinatal outcome of fetuses with polyhydramnios and/or accelerated growth among women with a normal oral glucose challenge test (oGCT).
Methods Singleton, nonanomalous pregnancies with an oGCT(< 130 mg/dL) at 24 to 28 weeks, who subsequently demonstrate polyhydramnios (amniotic fluid index > 24 cm or maximum vertical pocket > 8 cm) and/or accelerated growth (abdominal circumference > 95th percentile) on two-third trimester examinations were studied. Maternal demographics, delivery, and neonatal information were recorded. Cases were compared with a reference group (normal oGCT with neither abnormal third-trimester growth nor polyhydramnios).
Results A total of 282 pregnancies were in the study group, and 663 were in the reference group. Deliveries in the study group were at a higher risk for birth weight (BW)% > 90%, standard deviation, and postpartum hemorrhage when compared with the reference group (adjusted odds ratio: 2.3–5.6). Pregnancies complicated by both polyhydramnios and accelerated fetal growth were significantly more likely to result in a BW% > 90% (odds ratio [OR]: 18.5; 95% confidence interval [CI]: 8.9–38.6) and PPH (OR: 4.2; 95% CI: 2.4–7.6).
Conclusion Pregnancies with normal oGCT that develop polyhydramnios and accelerated growth are at higher risk for maternal and neonatal complications. Isolated polyhydramnios without accelerated growth increases the risk for delivery complications but not neonatal morbidity.
- 1 Carlson DE, Platt LD, Medearis AL, Horenstein J. Quantifiable polyhydramnios: diagnosis and management. Obstet Gynecol 1990; 75 (06) 989-993
- 2 Moise Jr KJ. Toward consistent terminology: assessment and reporting of amniotic fluid volume. Semin Perinatol 2013; 37 (05) 370-374
- 3 Chamberlain PF, Manning FA, Morrison I, Harman CR, Lange IR. Ultrasound evaluation of amniotic fluid volume. II. The relationship of increased amniotic fluid volume to perinatal outcome. Am J Obstet Gynecol 1984; 150 (03) 250-254
- 4 Phelan JP, Park YW, Ahn MO, Rutherford SE. Polyhydramnios and perinatal outcome. J Perinatol 1990; 10 (04) 347-350
- 5 Many A, Lazebnik N, Hill LM. The underlying cause of polyhydramnios determines prematurity. Prenat Diagn 1996; 16 (01) 55-57
- 6 Hill LM, Breckle R, Thomas ML, Fries JK. Polyhydramnios: ultrasonically detected prevalence and neonatal outcome. Obstet Gynecol 1987; 69 (01) 21-25
- 7 Pri-Paz S, Khalek N, Fuchs KM, Simpson LL. Maximal amniotic fluid index as a prognostic factor in pregnancies complicated by polyhydramnios. Ultrasound Obstet Gynecol 2012; 39 (06) 648-653
- 8 Biggio Jr JR, Wenstrom KD, Dubard MB, Cliver SP. Hydramnios prediction of adverse perinatal outcome. Obstet Gynecol 1999; 94 (5 Pt 1): 773-777
- 9 Chen KC, Liou JD, Hung TH. , et al. Perinatal outcomes of polyhydramnios without associated congenital fetal anomalies after the gestational age of 20 weeks. Chang Gung Med J 2005; 28 (04) 222-228
- 10 Wiegand SL, Beamon CJ, Chescheir NC, Stamilio D. Idiopathic polyhydramnios: severity and perinatal morbidity. Am J Perinatol 2016; 33 (07) 658-664
- 11 Smith CV, Plambeck RD, Rayburn WF, Albaugh KJ. Relation of mild idiopathic polyhydramnios to perinatal outcome. Obstet Gynecol 1992; 79 (03) 387-389
- 12 Panting-Kemp A, Nguyen T, Chang E, Quillen E, Castro L. Idiopathic polyhydramnios and perinatal outcome. Am J Obstet Gynecol 1999; 181 (5 Pt 1): 1079-1082
- 13 Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements--a prospective study. Am J Obstet Gynecol 1985; 151 (03) 333-337
- 14 Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144 (07) 768-773
- 15 O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964; 13: 278-285
- 16 Cheng YW, McLaughlin GB, Esakoff TF, Block-Kurbisch I, Caughey AB. Glucose challenge test: screening threshold for gestational diabetes mellitus and associated outcomes. J Matern Fetal Neonatal Med 2007; 20 (12) 903-908
- 17 Smith FG, Lumbers ER. Effects of maternal hyperglycemia on fetal renal function in sheep. Am J Physiol 1988; 255 (1 Pt 2): F11-F14
- 18 Reece EA, Hobbins JC. Diabetic embryopathy: pathogenesis, prenatal diagnosis and prevention. Obstet Gynecol Surv 1986; 41 (06) 325-335
- 19 Golan A, Wolman I, Saller Y, David MP. Hydramnios in singleton pregnancy: sonographic prevalence and etiology. Gynecol Obstet Invest 1993; 35 (02) 91-93
- 20 Lafont M, Dellinger P, Mutumba W, Bernard C, Hoyek T. Accuracy of ultrasound estimated fetal weight at term [in French]. Gynecol Obstet Fertil 2016; 44 (7-8): 391-395
- 21 Steinberg-Barkon G, Leibovitch L, Schushan-Eisen I, Gindes L, Strauss T, Maayan-Metzger A. Short- term perinatal outcome among term infants with prenatal diagnosis of large abdominal circumference. Am J Perinatol 2017; 34 (05) 465-470
- 22 Di Lorenzo G, Monasta L, Ceccarello M, Cecotti V, D'Ottavio G. Third trimester abdominal circumference, estimated fetal weight and uterine artery doppler for the identification of newborns small and large for gestational age. Eur J Obstet Gynecol Reprod Biol 2013; 166 (02) 133-138
- 23 Kehl S, Brade J, Schmidt U. , et al. Role of fetal abdominal circumference as a prognostic parameter of perinatal complications. Arch Gynecol Obstet 2011; 284 (06) 1345-1349
- 24 Bochner CJ, Medearis AL, Williams III J, Castro L, Hobel CJ, Wade ME. Early third-trimester ultrasound screening in gestational diabetes to determine the risk of macrosomia and labor dystocia at term. Am J Obstet Gynecol 1987; 157 (03) 703-708
- 25 Wilson-Leedy JG, DiSilvestro AJ, Repke JT, Pauli JM. Reduction in the cesarean delivery rate after obstetric care consensus guideline implementation. Obstet Gynecol 2016; 128 (01) 145-152